| Date Filed | Type | Description |
| 06/09/2023 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,136 options to buy
@ $45.69, valued at
$326k
|
|
| 02/27/2023 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 3,882 shares
@ $0
Disposed/sold 3,882 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| GEMAYEL GEORGES (Executive Chair of the Board) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 793,274 options to buy
@ $3.08, valued at
$2.4M
|
|
| 11/16/2021 |
4
| GEMAYEL GEORGES (See Remarks) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 23,514 options to buy
@ $3.58, valued at
$84.2k
Granted 17,245 options to buy
@ $3.58, valued at
$61.7k
|
|
| 05/03/2021 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 45,466 options to buy
@ $11.92, valued at
$542k
|
|
| 05/03/2021 |
3
| GEMAYEL GEORGES (Director) has filed a Form 3 on Gemini Therapeutics, Inc. /DE |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $12.64, valued at
$316k
Exercised 4,356 restricted stock units
@ $0 |
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 8,855 options to buy
@ $22.3, valued at
$197.5k
Granted 4,356 restricted stock units
@ $0
Exercised 5,734 restricted stock units
@ $0 |
|
| 02/27/2018 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 8,613 options to buy
@ $39.4, valued at
$339.4k
|
|
| 11/07/2017 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 44,474 options to buy
@ $4.85, valued at
$215.7k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2017 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 6,036 options to buy
@ $38.6, valued at
$233k
|
|
| 05/26/2017 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
| 02/27/2017 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC |
| 10/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2016 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Granted 32,069 options to buy
@ $7.08, valued at
$227k
|
|
| 04/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2013 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 15,188 restricted stock units
@ $0 |
|
| 10/17/2012 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 1,472 restricted stock units
@ $0 |
|
| 04/18/2012 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 837 restricted stock units
@ $0 |
|
| 03/01/2012 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 56,500 options to buy
@ $6.95, valued at
$392.7k
|
|
| 03/01/2012 |
3
| GEMAYEL GEORGES (Director) has filed a Form 3 on NPS PHARMACEUTICALS INC |
|